Background: Optimising therapeutic strategies of intermediate-risk non-muscle-invasive bladder cancer (IR-NMIBC) is needed.
Objective: To compare recurrence-free survival (RFS) with adjuvant intravesical mitomycin C (MMC) at normothermia or hyperthermia using the COMBAT bladder recirculation system at 43 °C for 30 and 60 min.
Design, Setting, And Participants: A prospective open-label, phase 3 randomised controlled trial (HIVEC-1) accrued across 13 centres between 2014 and 2020 in Spain.
Background: Bacillus Calmette-Guérin (BCG) maintenance therapy for 3 yr following BCG induction can reduce the progression of urothelial bladder carcinoma versus BCG induction alone, but is associated with high toxicity.
Objective: To investigate whether a modified 3-yr BCG maintenance regimen following induction therapy is more effective than standard BCG induction therapy alone and exhibits a low toxicity profile.
Design, Setting, And Participants: Patients from the outpatient clinics of the participating centres with high-risk non-muscle-invasive bladder carcinoma (NMIBC) were randomised between October 1999 and April 2007.
Objective: To report a case of ureteral inverted papilloma (IP) with laparoscopic resolution.
Methods: We report the case of a 30-year-old male patient who consulted for asymptomatic hematuria with the radiological finding of a filling defect at the distal right ureter. Ureteroscopy biopsy was not diagnostic, so laparoscopic ureterectomy with a Boari flap technique was performed.
Objective: We report a new case of benign retroperitoneal schwannoma arising from the adrenal gland.
Methods: 53 year old male with history of moderate benign prostatic hyperplasia under alpha blocker therapy who referred right flank discomfort for two months prior to last visit, without any other symptoms; radiologic examination with Ultrasound and CT scan and preoperative endocrine study were suggestive of non functioning adrenal tumour which was surgically extirpated.
Results: Anatomopathological report showed a benign juxta-adrenal schwannoma.